Actinium225QualityChecker
Actinium225
Actinium-225 Quality Checker — Actinium-225 for targeted alpha therapy (TAT)
ℹ️ Utility checks critical parameters of actinium-225:
• Specific activity (≥500 MBq/μmol for conjugates)
• Radiochemical purity (≥95%)
• Free actinium (≤5% for conjugates)
• Daughter nuclides: Fr-221, At-217, Bi-213, Tl-209
• pH, endotoxins, sterility, heavy metals
⚠️ CRITICAL: Free actinium >5% → bone/liver toxicity!
Daughter nuclides affect dosimetry and therapy efficacy!
Usage:
Actinium225QualityChecker.exe → demo mode (console output)
Actinium225QualityChecker.exe input.csv output.json → evaluate your data
Input format:
BatchNumber,SpecificActivityMBqPerUmol,RadiochemicalPurityPercent,FreeActiniumPercent,Francium221ImpurityPercent,Astatine217ImpurityPercent,Bismuth213ImpurityPercent,Thallium209ImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType
Example (sterility: 0=sterile, 1=contaminated):
AC225-PSMA-2026-001,600.0,97.0,3.0,1.5,0.5,2.0,0.8,5.5,100.0,0,5,PSMA-617
Supported product types:
• PSMA-617 — targeted alpha therapy for prostate cancer
• DOTATATE — targeted alpha therapy for neuroendocrine tumors
• FREEAC225 — unconjugated actinium-225 (for custom conjugation)
— WHY IS THIS NEEDED?
Actinium-225 — promising alpha-emitter for targeted alpha therapy (TAT):
• 10-day half-life — sufficient for synthesis and delivery
• 4 alpha particles in decay chain → high cytotoxicity
• Used in conjugates with PSMA-617, DOTATATE for metastatic cancer treatment
• Clinical trials show efficacy in resistant cancer forms
⚠️ CRITICAL:
• Specific activity ≥500 MBq/μmol — ensures sufficient dose for tumor cell destruction
• Free actinium ≤5% — UNBOUND actinium accumulates in bones and liver, causing toxicity!
• Daughter nuclides:
— Francium-221 (T½=4.8 min) — affects dosimetry
— Astatine-217 (T½=32 ms) — short-lived but critical for calculations
— Bismuth-213 (T½=46 min) — may detach from conjugate
— Thallium-209 (T½=2.2 min) — toxic to kidneys
• pH 4.0–7.0 — critical for blood compatibility during IV administration
• Endotoxins ≤175 EU/vial — critical for IV administration!
• Sterility — MANDATORY for all parenteral forms!
Key features:
• Support for different product types (conjugates and unconjugated actinium)
• Check of all 4 daughter nuclides in Ac-225 decay chain
• Specific limits for free actinium (≤5% for conjugates)
• Critical warnings about free actinium toxicity
• Automatic requirement determination based on product type
Critical parameters:
• Specific activity: ≥500 MBq/μmol (conjugates), ≥1000 MBq/μmol (unconjugated)
• Radiochemical purity: ≥95.0%
• Free actinium: ≤5.0% (conjugates), N/A (unconjugated)
• Francium-221: ≤2.0%
• Astatine-217: ≤1.0%
• Bismuth-213: ≤3.0%
• Thallium-209: ≤1.0%
• pH: 4.0–7.0
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Heavy metals: ≤10 ppm
💡 Usage tips:
1. For conjugates (PSMA-617, DOTATATE) free actinium control is critical
2. For unconjugated Ac-225 focus on specific activity and daughter nuclides
3. Daughter nuclides measured by alpha spectrometry
4. Free actinium controlled by TLC or HPLC
5. All measurements should be performed within 24 hours after synthesis
⚠️ Note: Actinium-225 is a NEW class of agents for targeted alpha therapy. Quality requirements are stricter than for beta-emitters due to high cytotoxicity of alpha particles. Even minor impurities can lead to serious side effects.
input.csv
BatchNumber,SpecificActivityMBqPerUmol,RadiochemicalPurityPercent,FreeActiniumPercent,Francium221ImpurityPercent,Astatine217ImpurityPercent,Bismuth213ImpurityPercent,Thallium209ImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType AC225-PSMA-2026-001,600.0,97.0,3.0,1.5,0.5,2.0,0.8,5.5,100.0,0,5,PSMA-617
URS & FS — user requirements and functional specification
This document defines user requirements and functional specification for the quality-control utility. It supports deployment discussion, IQ/OQ preparation and QC workflow integration.
1. Scope
The Actinium225 Quality Checker utility is used for Actinium225. The actual input.csv is the source of truth for the input structure; control criteria are defined by the executable and the domain description.
The utility does not use machine learning; decisions are produced by deterministic rules.
Categories: Radiopharmaceuticals
Tags: decay correction, endotoxins, heavy metals, impurities, microbiology, PET, radionuclide purity, radiopharma, SPECT, sterility
2. Execution modes
Actinium225QualityChecker.exe → demo mode (console output) Actinium225QualityChecker.exe input.csv output.json → evaluate your data
3. Key controlled areas
- purity and impurities
- microbiology and pathogens
- heavy metals / elemental impurities
- pH and physicochemical parameters
- activity, decay and radiochemical purity
4. Domain limits and critical parameters
- ℹ️ Utility checks critical parameters of actinium-225:
- Specific activity (≥500 MBq/μmol for conjugates)
- Radiochemical purity (≥95%)
- Free actinium (≤5% for conjugates)
- Daughter nuclides: Fr-221, At-217, Bi-213, Tl-209
- pH, endotoxins, sterility, heavy metals
- ⚠️ CRITICAL: Free actinium >5% → bone/liver toxicity!
- ⚠️ CRITICAL:
- Specific activity ≥500 MBq/μmol — ensures sufficient dose for tumor cell destruction
- Free actinium ≤5% — UNBOUND actinium accumulates in bones and liver, causing toxicity!
- Daughter nuclides:
- — Francium-221 (T½=4.8 min) — affects dosimetry
- — Astatine-217 (T½=32 ms) — short-lived but critical for calculations
- — Bismuth-213 (T½=46 min) — may detach from conjugate
- — Thallium-209 (T½=2.2 min) — toxic to kidneys
- pH 4.0–7.0 — critical for blood compatibility during IV administration
- Endotoxins ≤175 EU/vial — critical for IV administration!
- Sterility — MANDATORY for all parenteral forms!
- Support for different product types (conjugates and unconjugated actinium)
- Check of all 4 daughter nuclides in Ac-225 decay chain
- Specific limits for free actinium (≤5% for conjugates)
- Critical warnings about free actinium toxicity
- Automatic requirement determination based on product type
- Critical parameters:
5. URS — user requirements
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The system shall accept an input.csv file for Actinium225 with the exact columns listed in the “Input data contract” section. | High | A file with the correct header is processed without manual editing; missing mandatory columns produce FAIL/import error. |
| URS-002 | The system shall support execution without arguments in demo mode and execution with input.csv output.json for user data. | Medium | Both execution scenarios produce a predictable result or clear diagnostic error. |
| URS-003 | The system shall perform rule-based controls for: purity and impurities, microbiology and pathogens, heavy metals / elemental impurities, pH and physicochemical parameters, activity, decay and radiochemical purity. | High | Each controlled parameter receives a status and message; the result does not depend on hidden Excel formulas or ML. |
| URS-004 | The system shall preserve traceability between batch/lot, source values, applied rules and final verdict. | High | Output includes batch identifier, source values, parameter statuses and critical findings. |
| URS-005 | The system shall generate machine-readable output.json for LIMS/ELN/MES, batch record and QA/QC review. | High | JSON contains overall status, check array, warnings, failures and source-file reference. |
| URS-006 | The system shall support use in the client validation package: URS/FS, IQ/OQ preparation, installation and operational scenario checks. | High | The document, test scenarios and reproducible CSV/JSON flow are suitable for audit and internal approval. |
| URS-007 | The system shall clearly separate technical data errors from specification nonconformities. | Medium | Schema/type errors are not mixed with pharmacopoeial deviations and are reported separately. |
6. input.csv data contract
The source of truth for the input schema is the actual input.csv header. Column names are technical identifiers and are not translated.
| # | Column | Type | Unit | Description | Sample | Control rule |
|---|---|---|---|---|---|---|
| 1 | BatchNumber | identifier | as specified | Batch Number | AC225-PSMA-2026-001 | mandatory field; used for batch/lot traceability |
| 2 | SpecificActivityMBqPerUmol | decimal | MBq | Specific Activity MBq per Umol | 600.0 | mandatory numeric value; rule comparison is performed by the utility |
| 3 | RadiochemicalPurityPercent | decimal | % | Radiochemical Purity % | 97.0 | numeric value; compared with assay/purity limit from specification or method |
| 4 | FreeActiniumPercent | decimal | % | Free Actinium % | 3.0 | mandatory numeric value; rule comparison is performed by the utility |
| 5 | Francium221ImpurityPercent | decimal | % | Francium221 Impurity % | 1.5 | numeric value; compared with individual or total impurity limit |
| 6 | Astatine217ImpurityPercent | decimal | % | Astatine217 Impurity % | 0.5 | numeric value; compared with individual or total impurity limit |
| 7 | Bismuth213ImpurityPercent | decimal | % | Bismuth213 Impurity % | 2.0 | numeric value; compared with individual or total impurity limit |
| 8 | Thallium209ImpurityPercent | decimal | % | Thallium209 Impurity % | 0.8 | numeric value; compared with individual or total impurity limit |
| 9 | pH | decimal | pH | p H | 5.5 | mandatory numeric value; rule comparison is performed by the utility |
| 10 | EndotoxinsEU | decimal | as specified | Endotoxins EU | 100.0 | numeric value; critical safety attribute compared with endotoxin limit |
| 11 | SterilityTest | boolean / flag | 0/1 | Sterility Test | 0 | valid flag required; prohibited organisms and growth are normally expected as 0 / absent |
| 12 | HeavyMetalsPPM | decimal | ppm | Heavy Metals PPM | 5 | numeric value; checked as elemental/metal impurity |
| 13 | ProductType | text | as specified | Product Type | PSMA-617 | mandatory value; format and acceptability are checked by the utility |
CSV example
BatchNumber,SpecificActivityMBqPerUmol,RadiochemicalPurityPercent,FreeActiniumPercent,Francium221ImpurityPercent,Astatine217ImpurityPercent,Bismuth213ImpurityPercent,Thallium209ImpurityPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType AC225-PSMA-2026-001,600.0,97.0,3.0,1.5,0.5,2.0,0.8,5.5,100.0,0,5,PSMA-617
7. FS — functional specification
| ID | Function | Implementation description |
|---|---|---|
| FS-001 | CLI entry point | The executable Actinium225QualityChecker.exe supports demo mode and input.csv output.json processing mode. |
| FS-002 | CSV parser | The import module reads CSV, validates header, column presence/order, value count and encoding. Decimal values are expected with a dot separator. |
| FS-003 | Field conversion | Each column is converted to the expected type: identifier, text, decimal number, date/time or boolean flag. |
| FS-004 | Domain rule engine | For Actinium225, explicit rules are applied: range, minimum, maximum, absence of prohibited flag, data completeness or calculation-based check. |
| FS-005 | Criticality handling | Critical violations produce FAIL; non-critical deviations and incomplete data produce WARNING; full conformance produces PASS. |
| FS-006 | JSON writer | output.json stores overall status, per-parameter results, source values, warnings, failures and diagnostic messages. |
| FS-007 | Integration contract | The CSV → JSON format is stable for invocation from LIMS/ELN/MES, scheduled task or wrapper service. |
| FS-008 | Error handling | Schema error, missing file, non-numeric value or JSON write failure returns diagnosable error without silent PASS. |
8. output.json contract
The output file must be suitable for automated processing, audit review and correlation with the source input.csv row.
{
"utility": "Actinium225QualityChecker",
"api": "Actinium225",
"batchNumber": "AC225-PSMA-2026-001",
"overallStatus": "PASS|WARNING|FAIL",
"checkedAtUtc": "2026-05-18T00:00:00Z",
"checks": [
{
"parameter": "BatchNumber",
"value": "AC225-PSMA-2026-001",
"unit": "as specified",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "SpecificActivityMBqPerUmol",
"value": "600.0",
"unit": "MBq",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "RadiochemicalPurityPercent",
"value": "97.0",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "FreeActiniumPercent",
"value": "3.0",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Francium221ImpurityPercent",
"value": "1.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Astatine217ImpurityPercent",
"value": "0.5",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Bismuth213ImpurityPercent",
"value": "2.0",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Thallium209ImpurityPercent",
"value": "0.8",
"unit": "%",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": [],
"sourceFile": "input.csv"
}9. OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| TC-001 | Valid CSV with expected header and sample row | All rows are processed; output contains PASS/WARNING/FAIL and parameter-level detail. |
| TC-002 | A mandatory input.csv column is missing | Import is rejected or the row receives FAIL with schema reference. |
| TC-003 | A numeric field contains text or a blank value | Type conversion error is recorded; the result is not hidden as PASS. |
| TC-004 | A parameter is outside specification or critical limit | Critical parameters produce FAIL; non-critical deviations produce WARNING according to the rule. |
| TC-005 | Positive pathogen/microbiological flag or microbiological limit excursion | Critical FAIL is produced with the offending parameter. |
| TC-008 | Incorrect activity, reference time or radiochemical purity | FAIL/WARNING is produced with calculation traceability. |
10. QA/QC, CSV and change control
- Before production use, the client records executable version, checksum, specification/monograph version, test CSV, expected JSON and IQ/OQ results.
- Column names must not be changed without updating the validator and test scenarios.
- The source CSV, output.json and utility version should be stored together as an evidence package.
- Any change in control rules must go through change control and repeated OQ scenario verification.
Included in packages
Andrology QC Suite
QC package for andrology: androgens, erectile-dysfunction medicines, BPH/prostate products, fertility and related hormonal checks.
OpenEndocrinology QC Suite
QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.
OpenGastroenterology QC Suite
QC package for gastroenterology: PPIs, antiemetics, prokinetics, IBD medicines, laxatives, enzymes and GI anti-infectives.
OpenNeurology QC Suite
QC package for neurology and neuropsychiatry: antiepileptics, antiparkinsonian medicines, antidepressants, antipsychotics, analgesics and neurological diagnostic radiopharmaceuticals.
OpenPetRad QC Suite
A specialised utility package for radiopharmaceutical quality control: PET, SPECT, therapeutic radionuclides, generators and decay calculations.
OpenRadiology QC Suite
QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.
OpenRPH isotope family: alpha-emitting therapy
Ac-225, Ra-223, At-211, Bi-213 and Th-227: targeted alpha therapy and daughter/recoil control.
OpenRPH organ/system: bone and musculoskeletal
Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.
OpenRPH organ/system: brain and CNS
Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.
OpenRPH organ/system: endocrine, thyroid and NET
Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.
OpenRPH organ/system: hepatobiliary and GI
HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.
OpenRPH organ/system: oncology and theranostics
Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.
OpenRPH organ/system: renal and urinary
Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.
OpenRPH use case: radionuclide therapy and theranostics
Lu-177, Ac-225, Ra-223, Y-90, Ho-166, Sm-153, Sr-89, Re-188, Tb-161, I-131 and other therapeutic radiopharmaceuticals: activity, purity, free metal, daughters and toxicological constraints.
OpenRPH workflow: dosimetry and therapy planning
Activity planning, absorbed dose, organ dose, lung shunt, preplanning and therapy verification.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH workflow: stability, storage, decay and waste
Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.
OpenRPH workflow: synthesis, labelling and kit reconstitution
Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.
OpenRPH: combined radiopharmaceutical QC package
RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.
OpenUrology QC Suite
QC package for urology: BPH, urolithiasis, overactive bladder, urinary-tract infection medicines and supporting antimicrobial QC checks.
Open